
Atrion Corporation ATRI
Annual report 2023
added 02-29-2024
Atrion Corporation ROCE Ratio 2011-2025 | ATRI
Annual ROCE Ratio Atrion Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.3 | 16.57 | 14.75 | 14.83 | 16.16 | 18.87 | 21.26 | 22.55 | 27.42 | 25.26 | 23.32 | 22.63 | 25.13 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.42 | 9.3 | 19.85 |
Quarterly ROCE Ratio Atrion Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.9 | 7.8 | 12.27 | 12.54 | 16.5 | 16.56 | 16.15 | 11.68 | 14.83 | 14.03 | 14.13 | 12.2 | 15.42 | 16.66 | 17.1 | 16.86 | 18.51 | 19.22 | 19.96 | 20.71 | 20.11 | 21.23 | 21.41 | 22.16 | 22.29 | 22.8 | 23.46 | 23.74 | 24.71 | 26.01 | 27.54 | 29.09 | 29.06 | 28.54 | 27.68 | 26.86 | 26.64 | 26.33 | 25.84 | 25.0 | 24.61 | 24.6 | 24.87 | 24.46 | 24.74 | 24.79 | 25.67 | 27.07 | 7.22 | 7.53 | 7.29 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 29.09 | 3.9 | 20.01 |
ROCE Ratio of other stocks in the Medical instruments industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
-2.04 | $ 24.56 | 0.7 % | $ 1.13 B | ||
|
Baxter International
BAX
|
0.2 | $ 19.52 | 1.93 % | $ 9.96 B | ||
|
Becton, Dickinson and Company
BDX
|
10.16 | $ 200.48 | -0.23 % | $ 57.7 B | ||
|
Luminex Corporation
LMNX
|
5.75 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-131.33 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
-82.32 | $ 4.68 | 0.21 % | $ 94.4 M | ||
|
Antares Pharma, Inc.
ATRS
|
9.12 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
2.55 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-3.75 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.0 | - | -0.05 % | $ 10.3 B | ||
|
Harvard Bioscience
HBIO
|
2.59 | $ 0.71 | -4.45 % | $ 30.1 M | ||
|
Varian Medical Systems, Inc.
VAR
|
17.41 | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
2.19 | $ 148.28 | -0.1 % | $ 3.62 B | ||
|
iRhythm Technologies
IRTC
|
-127.06 | $ 170.21 | 0.82 % | $ 5.31 B | ||
|
Alcon
ALC
|
-2.56 | $ 79.15 | 0.43 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
-8.68 | $ 41.07 | -3.09 % | $ 1.93 B | ||
|
electroCore
ECOR
|
-258.92 | $ 4.85 | 2.11 % | $ 26.7 K | ||
|
Repro Med Systems
KRMD
|
-50.46 | $ 5.8 | 0.35 % | $ 264 M | ||
|
AngioDynamics
ANGO
|
-21.84 | $ 13.42 | 2.13 % | $ 548 M | ||
|
The Cooper Companies
COO
|
8.29 | $ 81.36 | -0.88 % | $ 16.2 B | ||
|
LeMaitre Vascular
LMAT
|
15.49 | $ 83.04 | -1.14 % | $ 1.86 B | ||
|
Glaukos Corporation
GKOS
|
-27.87 | $ 111.73 | 2.6 % | $ 5.41 B | ||
|
Masimo Corporation
MASI
|
-25.35 | $ 137.35 | -0.72 % | $ 7.32 B | ||
|
Haemonetics Corporation
HAE
|
27.02 | $ 80.24 | -3.89 % | $ 4.04 B | ||
|
InfuSystem Holdings
INFU
|
3.45 | $ 9.22 | -0.27 % | $ 190 M | ||
|
Merit Medical Systems
MMSI
|
11.29 | $ 86.49 | -0.24 % | $ 5.04 B | ||
|
Isoray
ISR
|
-31.27 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
14.29 | $ 559.7 | 3.2 % | $ 199 B | ||
|
OraSure Technologies
OSUR
|
-6.33 | $ 2.49 | - | $ 185 M | ||
|
Microbot Medical
MBOT
|
-218.95 | $ 2.23 | -7.65 % | $ 22.7 M | ||
|
Milestone Scientific
MLSS
|
-115.85 | $ 0.36 | -7.4 % | $ 28.7 M | ||
|
Nephros
NEPH
|
-19.06 | $ 4.98 | -0.8 % | $ 51.7 M | ||
|
NeuroMetrix
NURO
|
-61.36 | - | 5.05 % | $ 9.02 M | ||
|
ResMed
RMD
|
22.7 | $ 251.67 | -0.27 % | $ 36.8 B | ||
|
Envista Holdings Corporation
NVST
|
-35.38 | $ 22.07 | 0.46 % | $ 3.8 B | ||
|
Pro-Dex
PDEX
|
22.96 | $ 44.0 | 1.43 % | $ 145 M | ||
|
STAAR Surgical Company
STAA
|
-3.17 | $ 23.49 | -2.65 % | $ 1.15 B | ||
|
STERIS plc
STE
|
13.12 | $ 253.98 | 0.82 % | $ 25 B | ||
|
Stereotaxis
STXS
|
-133.63 | $ 2.35 | -1.05 % | $ 190 M | ||
|
Pulse Biosciences
PLSE
|
-98.23 | $ 14.04 | -1.4 % | $ 674 M | ||
|
Predictive Oncology
POAI
|
5399.27 | - | - | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
1.79 | $ 160.09 | 1.72 % | $ 8.92 M | ||
|
Utah Medical Products
UTMD
|
13.08 | $ 57.54 | -0.96 % | $ 209 M | ||
|
DENTSPLY SIRONA
XRAY
|
-45.26 | $ 11.43 | -1.21 % | $ 2.32 B | ||
|
Retractable Technologies
RVP
|
-24.21 | $ 0.84 | 1.99 % | $ 25.1 M | ||
|
Teleflex Incorporated
TFX
|
3.53 | $ 126.88 | 0.17 % | $ 5.94 B | ||
|
West Pharmaceutical Services
WST
|
21.25 | $ 271.82 | 1.6 % | $ 19.8 B |